Overview
A few for my peers answered some questions, but I wanted to see if there were any additional points to add to the first question? Can you give another example for the medical field? Can you think of any additional pro/cons for the second question?
1.(a) How do economists use the Hirschman-Herfindahl Index? (b) Provide an example.
a) Economists use the Hirschman-Herfindahl Index (HHI) as a metric to assess the level of market concentration and the competitive environment. This index measures the distribution of market shares among businesses in an industry. Economists can assess if a market is controlled by a small number of firms or is characterized by strong competition by looking at the HHI. A higher HHI denotes a competitive market with many businesses having roughly equal shares, whereas a lower HHI denotes a market where a small number of businesses maintain significant influence, potentially leading to a monopolistic condition. As an example of a practical use, the HHI is used by regulatory agencies like the Federal Trade Commission and the Department of Justice to evaluate mergers and acquisitions (Duane Morris LLP, 2023). These authorities are able to foresee how a merger would affect competition in the market with the use of the index.
b) Evren et al. (2021) note that while the HHI is a popular and straightforward measure, it has limitations, such as its linearity and the potential for misinterpretation in oligopolistic versus monopolistic market structures. To address these limitations, new indices that are derived from qualitative variation and entropy measures, aim to provide a more nuanced understanding of market dominance. The application of these indices to the Turkish car market in 2019 reveals that despite the HHI indicating a moderately concentrated market, other dominance indices suggest a higher level of concentration, highlighting the importance of considering multiple measures when assessing market competition.
2. (a) What are the pros and cons of merger activity? (b) Why would the government want to prevent mergers in the health services industry?
A. Pros & Cons of Merger Activity
Hospital mergers can add significant value by enabling economies of scale, resulting in increased efficiency and lower costs. These efficiencies frequently result in increased capacities in terms of the breadth and quality of healthcare services provided (Borha, 2023). On the other hand, these mergers might have negative consequences like less competition, which can lead to increased healthcare costs and lower service quality over time. Integration of several hospital systems can also provide considerable issues, harming employee morale and patient service continuity (Borha, 2023).
However, there are significant drawbacks to mergers. They can lead to decreased competition, which can raise costs and limit customer options as fewer rivals remain in the market. The integration of several company cultures and systems can present major operational issues, potentially leading to cost increases. Furthermore, significant mergers can develop or strengthen monopoly power, allowing dominant businesses to engage in anti-competitive behavior that harms both consumers and the market.
B. Government Prevention of Mergers in the Health Services Industry
The government's role in regulating mergers in the healthcare sector is critical for avoiding negative consequences from diminished competition. The government's goal in regulating and occasionally opposing mergers is to minimize the formation of monopolies or oligopolies, which might raise healthcare costs and limit patient access to essential services. The goal is to maintain a competitive market that encourages continual development in quality and efficiency, ensuring that healthcare is accessible and cheap to all customers (Mwachofi & Al-Assaf, 2011)